AlphAIAlphAI — Financial news for AI agents
prnewswire.comSEP 221 min read$NUTX

Nutex Health Approved for Dual Listing on Nasdaq Texas

Nutex Health (NASDAQ: NUTX) received approval to dual-list its common stock on Nasdaq Texas, with trading expected to begin September 23, 2026. The company will maintain its listing on the Nasdaq Global Market under the same ticker symbol, NUTX. The dual listing aims to increase visibility among regional investors while keeping its national and international presence.

Original reporting
prnewswire.com
Published Sep 22, 2026, 11:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 11:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$NUTX
Neutral
medium confidence
Mentioned
$NUTX
Relevance
5/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$NUTXNeutralLow
01

Why it matters

The dual‑listing expands the company's market presence without altering its capital structure, offering modest liquidity benefits.

02

Market read

A corporate action that may slightly improve trading dynamics for Nutex Health, with limited broader market impact.

03

What to watch

Potential regulatory scrutiny of the new venue and any future trading fee differences.

Relevance 5/10Novelty 6/10Timing: effective Sept 23, 2026 (market open)

Background

Nutex Health is a physician‑led healthcare services company operating 28 hospitals across 12 states.

Company-level read

Ticker impact

$NUTXNeutralMedium confidence
Context

Nutex Health received SEC approval to dual‑list its common stock on Nasdaq Texas, with trading expected to start on Sept. 23, 2026.

Expected impact

Modest upside potential as new venue adds trading depth; no immediate large price move expected.

Evidence & confidence

The approval is a new corporate action but involves no capital raise or material financial change.

Market effects

Sector

Highlights growing interest in healthcare services stocks on regional exchanges.

Regional

May attract Texas‑based institutional investors to Nutex Health.

Global

Limited; primarily affects US investors and regional market participants.

Counterpoint

What could challenge this read

The dual‑listing could be a distraction; without operational growth the impact may be negligible.

Key entities

  • Executive
    Tom Vo

    Chairman and CEO of Nutex Health, quoted on the dual‑listing approval.

  • Exchange
    Nasdaq Texas

    The new trading venue where Nutex Health will be listed.

Read at source← All news

Related articles

AUG 25
$NUTXMed

Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act

Nutex Health (NASDAQ: NUTX) commented on a Fifth Circuit ruling invalidating federal QPA calculation rules under the No Surprises Act, which the company says artificially deflated payments. The court ruled insurers cannot include non-negotiated 'ghost rates' and must include bonus payments in QPA calculations. Nutex Health expects this to lead to fairer upfront payments for providers. The ruling may impact the company's financials, but the timeline for new regulations is uncertain.

prnewswire.com2 min
AUG 13
$NUTXMedAI 8/10

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported Q2 2026 results on an earnings call. Total revenue fell to $210.8M from $244.0M. Net income rose to $65.8M, diluted EPS to $9.38, and adjusted EBITDA to $90.0M. Management cited lower contract services costs from a HaloMD amendment and higher patient visits, plus a hospital expansion pipeline.

fool.com7 min
AUG 10
$NUTXMedAI 8/10

Nutex Health Q2 Profit Soars As IDR Cost Reductions Drive Margin Gains

Nutex Health (NUTX) reported Q2 2026 results, with net income of $65.8M and diluted EPS of $9.38, versus a net loss of $17.7M a year earlier. Revenue fell 13.6% to $210.8M. The company cited IDR-related cost reductions, including a $52.3M contract services expense decline, and expects normalized historical expenses to drop 25% to 30% prospectively. Shares rose 14.88% to $186.19.

rttnews.com4 min
AUG 6
$NUTXMed

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Nutex Health Inc. (NASDAQ: NUTX) reported Q2 2026 results for the three and six months ended June 30, 2026. Net income attributable rose to $65.8M (diluted EPS $9.38) for Q2, versus a loss in 2025. Six-month net income was $112.6M (EPS $15.87). Revenue fell to $427.2M for six months. Operating cash flow was $109.7M. Hospital visits increased.

prnewswire.com6 min
AUG 6
$NUTXMed

NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Nutex Health Inc. (NUTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. NUTEX HEALTH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS HOUSTON, TX − (PRNewswire) – AUGUST 6, 2026 – Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), today announced financial results for the three and six months ended June 30, 2026. Nutex Health is a physi

SEC EDGAR 8-K7 min
OCT 12
$GETYHighAI 8/10

A U.S. bankruptcy filing is planned for Getty Images, while operations are expected to continue normally.

Getty Images (OTCPK: GETY) plans to file for Chapter 11 bankruptcy to restructure its balance sheet and address legal liabilities. The company secured support from major stakeholders, including the Getty family and Koch Equity Development, for a prepackaged reorganization. Operations will continue normally, and the process is expected to complete by year-end.

stocktitan.net6 min